Brokerages Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Price Target at $50.39

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine analysts that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $50.39.

ACHC has been the topic of a number of recent analyst reports. Royal Bank of Canada reduced their price target on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Bank of America decreased their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. KeyCorp decreased their price objective on shares of Acadia Healthcare from $70.00 to $65.00 and set an "overweight" rating on the stock in a report on Monday, March 3rd. StockNews.com downgraded shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Monday, January 6th. Finally, Mizuho dropped their price objective on shares of Acadia Healthcare from $48.00 to $37.00 and set a "neutral" rating for the company in a research report on Tuesday, March 25th.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC traded up $0.53 during midday trading on Thursday, reaching $23.31. 1,937,486 shares of the company traded hands, compared to its average volume of 1,623,265. Acadia Healthcare has a 12 month low of $20.36 and a 12 month high of $82.41. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock's 50-day simple moving average is $27.61 and its 200-day simple moving average is $37.59. The firm has a market cap of $2.15 billion, a PE ratio of 7.64, a PEG ratio of 1.46 and a beta of 1.01.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors have recently made changes to their positions in the stock. Lindbrook Capital LLC grew its position in shares of Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after buying an additional 671 shares during the period. Blue Trust Inc. raised its holdings in Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock worth $33,000 after purchasing an additional 345 shares during the period. UMB Bank n.a. boosted its position in shares of Acadia Healthcare by 149.5% during the first quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock worth $38,000 after purchasing an additional 755 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares in the last quarter. Finally, Signaturefd LLC raised its stake in Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after buying an additional 1,004 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.